Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Common side effects from clinical trials The most frequently reported adverse events with retatrutide mirror those of other GLP-1 based medications
Many employers believed that coverage was an important benefit that was valued by employees
Some estimates suggest that if just 10% of eligible employees started GLP-1 therapy, employer health costs could increase by 15% to 25%
The topline results showed that in adults with obesity or who are overweight and have type 2 diabetes, the drug provided significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors at 72 weeks
US$ 22.50
US$ 24.92
US$ 21.82
US$ 28.81
